UroGen Pharma has broadened its oncology pipeline by acquiring IconOVir Bio’s assets related to the oncolytic virus ICVB-1042 ...

More than five years on, studies suggest the animal is the most likely culprit, but other candidates haven't been ruled out.

UroGen Pharma (NASDAQ:URGN) stock in focus as company acquires oncolytic virus ICVB-1042 from IconOVir Bio, to design ...

UroGen Pharma has opened another front in its attack on bladder cancer, paying IconOVir Bio $4 million in stock for an early-phase oncolytic virus that could work like a turbocharged Bacillus Calmette ...

It’s hard to say something nice about viruses, but Dr. Joaquín Martínez Martínez can. Dr. Martínez Martínez is a new aquatic ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...

Replimune's innovative cancer therapies, strong cash reserves, and FDA support position it to disrupt oncology markets. Click ...

Despite their potential, oncolytic viruses encounter several challenges as standalone therapies. Consequently, the combination of oncolytic viruses with other therapeutic modalities has emerged as a ...

Oncolytic viruses (OVs) are viruses that infect and kill cancer cells while sparing healthy tissue, making them a promising therapeutic option in cancer ...

The H5N1 virus, which made its way to the United States in 2022, has infected or killed millions of birds and infected many other animals In just the last three months, more… ...

Oncolytic viruses are therapeutic agents used for in situ immunization in cancer immunotherapy. Unfortunately, its efficacy is particularly limited in solid tumors expressing stimulator of interferon ...

Sneezing, fever, chills, vomiting, coughing — it’s not just one virus wreaking havoc this winter ... shortness of breath and bluish colour around the lips or fingers. 2:01 RSV, influenza ...